The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips

Annals of Biomedical Engineering

Volumn 40, Issue 6, 2012, Pages 1228-1243

  Prot, Jean Matthieu ^a   Leclerc, Eric ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

Author keywords

Alternative methods; Cytomics; Liver; Metabolomics; Microfluidic biochips; PBPK models; Predictive toxicology; Proteomics; Transcriptomics

Indexed keywords

ALTERNATIVE METHODS; CYTOMICS; METABOLOMICS; MICRO FLUIDIC BIOCHIPS; PREDICTIVE TOXICOLOGY; PROTEOMICS; TRANSCRIPTOMICS;

ANIMAL CELL CULTURE; BIOASSAY; BIOCHIPS; LIVER; MOLECULAR BIOLOGY;

MICROFLUIDICS;

ANIMAL; BIOLOGICAL MODEL; CELL STRAIN 3T3; CELL STRAIN HEPG2; DOG; HUMAN; INSTRUMENTATION; LIVER; METABOLOMICS; METHODOLOGY; MICROFLUIDIC ANALYSIS; MOUSE; PROTEOMICS; REVIEW; TOXICOLOGY;

3T3 CELLS; ANIMALS; DOGS; HEP G2 CELLS; HUMANS; LIVER; METABOLOMICS; MICE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PROTEOMICS; TOXICOLOGY;

EID: 84862153039     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-011-0480-5     Document Type: Article

References (88)

1. VC Abraham DL Taylor JR Haskins 2004 High content screening applied to large-scale cell biology Trends Biotechnol. 22 15 22 14690618 10.1016/j.tibtech.2003.10.012 1:CAS:528:DC%2BD3sXpvFyrs7g%3D (Pubitemid 38030316)
2. DR Albrecht GH Underhill J Resnikoff A Mendelson SN Bhatia JV Shah 2010 Microfluidics-integrated time-lapse imaging for analysis of cellular dynamics Integr. Biol. 2 278 287 10.1039/b923699f 1:CAS:528:DC%2BC3cXovVGks7k%3D
3. J Anderson D Chiu J McDonald R Jackman O Cherniavskaya H Wu S Whitesides G Whitesides 2000 Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping Anal. Chem. 72 3158 3164 10939381 10.1021/ac9912294 1:CAS:528:DC%2BD3cXjvVamtLg%3D (Pubitemid 30482485)
4. C Aninat A Piton D Glaise T Le Charpentier S Langouet F Morel, et al. 2006 Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells Drug Metab. Dispos. 34 75 83 16204462 10.1124/dmd.105.006759 1:CAS:528:DC%2BD28Xhslyjtg%3D%3D (Pubitemid 43042648)
5. R Baudoin A Corlu L Griscom C Legallais E Leclerc 2007 Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity Toxicol. In Vitro 21 535 544 17188836 10.1016/j.tiv.2006.11.004 1:CAS:528: DC%2BD2sXkt1aktro%3D (Pubitemid 46566396)
6. R Baudoin L Griscom JM Prot C Legallais E Leclerc 2011 Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor Biochem. Eng. J. 53 172 181 10.1016/j.bej.2010.10.007 1:CAS:528:DC%2BC3cXhsFCqsr%2FJ
7. H Becker C Gärtner 2000 Polymer microfabrication methods for microfluidic analytical applications Electrophoresis 21 12 26 10634467 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.0.CO;2-7 1:CAS:528:DC%2BD3cXlsFKhtg%3D%3D (Pubitemid 30032693)
8. R Beger J Sun L Schnackenberg 2010 Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity Toxicol. Appl. Pharmacol. 243 154 166 19932708 10.1016/j.taap.2009.11.019 1:CAS:528:DC%2BC3cXit1Ogt7o%3D
9. SN Bhatia ML Yarmush M Toner 1997 Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts J. Biomed. Mater. Res. 34 189 199 9029299 10.1002/(SICI)1097-4636(199702)34:2<189::AID- JBM8>3.0.CO;2-M 1:STN:280:DyaK2s7otFWgug%3D%3D (Pubitemid 27073810)
10. N Bhogal C Grindon R Combes M Balls 2005 Toxicity testing: creating a revolution based on new technologies Trends Biotechnol. 23 299 307 15922082 10.1016/j.tibtech.2005.04.006 1:CAS:528:DC%2BD2MXks1Cmsrg%3D (Pubitemid 40726271)
11. BJ Blaauboer ME Andersen 2007 The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative Arch. Toxicol. 81 385 387 17262219 10.1007/s00204-006-0175-0 1:CAS:528:DC%2BD2sXkvFKisrc%3D (Pubitemid 46701597)
12. N Blanchard E Alexandre C Abadie T Lavé B Heyd G Mantion D Jaeck L Richert P Coassolo 2005 Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes Xenobiotica 35 1 15 15788364 10.1080/00498250400021820 1:CAS:528:DC%2BD2MXisVyis78%3D (Pubitemid 40459213)
13. N Blanchard L Richert B Notter F Delobel P David P Coassolo T Lavé 2004 Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes Eur. J. Pharm. Sci. 23 189 199 15451007 10.1016/j.ejps.2004.07.007 1:CAS:528:DC%2BD2cXnvV2rs7k%3D
14. DR Boverhof LD Burgoon C Tashiro B Sharratt B Chittim JR Harkema, et al. 2006 Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice Toxicol. Sci. 94 398 416 16960034 10.1093/toxsci/kfl100 1:CAS:528:DC%2BD28XhtlWnsrbO (Pubitemid 44817156)
15. P Chao T Maguire E Novik KC Cheng ML Yarmush 2009 Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human Biochem. Pharmacol. 78 625 632 19463793 10.1016/j.bcp.2009.05.013 1:CAS:528:DC%2BD1MXpt1KlsL4%3D
16. S Charati S Stern 1998 Diffusion of gases in silicone polymer: molecular dynamics simulations Macromolecules 31 5529 5535 10.1021/ma980387e 1:CAS:528:DyaK1cXkvFKmu74%3D (Pubitemid 128569555)
17. Cheng, S., J. M. Prot, E. Leclerc, and F. Y. Bois. Zonation-related pathways in human hepatocellular carcinoma cells in dynamic vs. static culture microenvironments. BMC Genomics, 2011 (to appear).
18. Choucha-Snouber, L., L. Griscom, P. E. Poleni, F. Razan, C. Brochot, C. Aninat, A. Corlu, C. Legallais, and E. Leclerc. Liver kidney microfluidic bioreactor for cell coculture in drug studies. In: Proceedings of the Miniaturized Total Analysis System, μTAS, Conference 2010, Groningen, The Netherlands.
19. N Claude F Goldfain-Blanc A Guillouzo 2009 La place des methods in silico, in vitro, in omic dans l'évaluation de la sécurité des medicaments Med. Sci. 25 105 110
20. K Domansky W Inman J Serdy A Dash MH Lim LG Griffith 2010 Perfused multiwell plate for 3D liver tissue engineering Lab Chip 10 51 58 20024050 10.1039/b913221j 1:CAS:528:DC%2BD1MXhsFaksLfL
21. JF Dorn G Danuser G Yang 2008 Computational processing and analysis of dynamic fluorescence image data Methods Cell Biol. 85 497 538 18155477 10.1016/S0091-679X(08)85022-4 1:CAS:528:DC%2BD1cXhtVGrsrc%3D
22. ME Dumas R Barton A Toye O Cloarec C Blancher A Rothwell J Fearnside R Tatoud V Blanc J Lindon SV Mitchell E Holmes MI McCarthy J Scott D Gauguier J Nicholson 2006 Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc. Natl. Acad. Sci. USA 103 12511 12516 16895997 10.1073/pnas.0601056103 1:CAS:528:DC%2BD28Xos12qu7s%3D (Pubitemid 44267289)
23. G Eisenbrand B Pool-Zobel V Baker M Balls BJ Blaauboer A Boobis, et al. 2002 Methods of in vitro toxicology Food Chem. Toxicol. 40 193 236 11893398 10.1016/S0278-6915(01)00118-1 1:CAS:528:DC%2BD38XhvVequrg%3D (Pubitemid 34228905)
24. E Eschbach SS Chatterjee M Noldner E Gottwald H Dertinger KF Weibezahn G Knedlitschek 2005 Microstructured scaffolds for liver tissue cultures of high cell density: morphological and biochemical characterization of tissue aggregates J. Cell. Biochem. 95 243 255 15770659 10.1002/jcb.20360 1:CAS:528:DC%2BD2MXktFKjs7s%3D (Pubitemid 41420195)
25. O Fiehn J Kopka P Dörmann T Altmann RN Trethewey L Willmitzer 2000 Metabolite profiling for plant functional genomics Nat. Biotechnol. 18 1157 1161 11062433 10.1038/81137 1:CAS:528:DC%2BD3cXotVSmtL0%3D
26. D Figeys 2004 Combining different 'omics' technologies to map and validate protein-protein interactions in humans Brief Funct Genomic Proteomics 2 357 365 10.1093/bfgp/2.4.357 1:CAS:528:DC%2BD2cXjtFyrtrc%3D
27. M Gibney M Walsh L Brennan H Roche B German B van Ommen 2005 Metabolomics in human nutrition: opportunities and challenges Am. J. Clin. Nutr. 82 497 503 16155259 1:CAS:528:DC%2BD2MXhtVaksL%2FM
28. H Greim 2007 Toxicological comments to the discussion about REACH (H. Greim, M. Arand, H. Autrup, H.M. Bolt, J. Bridges, E. Dybing, R. Glomot, V. Foa, R. Schulte-Hermann, Arch Toxicol 2006, 80: 121-124). Reply to the letter to the editor: the need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative, by B.J. Blaauboer and M.E. Andersen (Arch Toxicol 2007, 81: 385-387). Arch. Toxicol. 80 121 124 10.1007/s00204-005-0039-z
29. SJ Griffin JB Houston 2005 Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures Drug Metab. Dispos. 33 115 120 15608354 1:CAS:528:DC%2BD2MXltleguw%3D%3D (Pubitemid 40023522)
30. L Griffith G Naughton 2002 Tissue engineering-current challenges and expanding opportunities Science 295 1009 1014 11834815 10.1126/science.1069210 1:CAS:528:DC%2BD38Xht1GksL0%3D (Pubitemid 34132215)
31. P Gripon S Rumin S Urban J Le Seyec D Glaise I Cannie, et al. 2002 Infection of a human hepatoma cell line by hepatitis B virus Proc. Natl. Acad. Sci. USA 99 15655 15660 12432097 10.1073/pnas.232137699 1:CAS:528:DC%2BD3sXjvV2r (Pubitemid 35403987)
32. B Haenen C Rompelberg K Van Twillert M Hamzink J Dormans J Van Eljkeren 2001 Utility of rat liver slices to estimate hepatic clearance for application in physiologically based pharmacokinetic modeling: a study with tolbutamide, a compound with low extraction efficiency Drug Metab. Dispos. 30 307 313 10.1124/dmd.30.3.307 (Pubitemid 34176810)
33. SA Haney P LaPan J Pan J Zhang 2006 High-content screening moves to the front of the line Drug Discov. Today 11 889 894 16997138 10.1016/j.drudis.2006. 08.015 1:CAS:528:DC%2BD28XpvFSisrg%3D (Pubitemid 44403188)
34. T Hartung C Rovida 2009 Chemical regulators have overreached Nature 460 1080 1081 19713914 10.1038/4601080a 1:CAS:528:DC%2BD1MXhtVGitbfK
35. G Herrera L Diaz A Martinez-Romero A Gomes E Villamon RC Callaghan, et al. 2007 Cytomics: a multiparametric, dynamic approach to cell research Toxicol. In Vitro 21 176 182 16934431 10.1016/j.tiv.2006.07.003 1:CAS:528: DC%2BD2sXhs1SlsLs%3D (Pubitemid 46205071)
36. NJ Hewitt KU Bühring J Dasenbrock J Haunschild B Ladstetter D Utesch 2001 Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures Drug Metab. Dispos. 29 1042 1050 11408372 1:CAS:528:DC%2BD3MXksFCnt70%3D (Pubitemid 32605921)
37. JB Houston 1994 Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics Toxicol. In Vitro 8 507 512 20692946 10.1016/0887-2333(94)90002-7 1:CAS:528:DyaK2cXmslWjsLk%3D
38. JB Houston DJ Carlile 1997 Prediction of hepatic clearance from microsomes, hepatocytes and liver slices Drug Metab. Rev. 29 891 922 9421679 10.3109/03602539709002237 1:CAS:528:DyaK1cXhtlGktw%3D%3D (Pubitemid 28133451)
39. K Ito JB Houston 2004 Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes Pharm. Res. (NY) 21 785 792 10.1023/B:PHAM.0000026429. 12114.7d 1:CAS:528:DC%2BD2cXjs1Kisr8%3D (Pubitemid 39011301)
40. T Iwatsubo N Hirota T Ooie H Suzuki N Shimada K Chiba T Ishizaki CE Green CA Tyson Y Sugiyama 1997 Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data Pharmacol. Ther. 73 147 171 9131722 10.1016/S0163-7258(96)00184-2 1:STN:280:DyaK2s3nvVCgsg%3D%3D (Pubitemid 27191615)
41. BJ Kane MJ Zinner ML Yarmush M Toner 2006 Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes Anal. Chem. 78 4291 4298 16808435 10.1021/ac051856v 1:CAS:528:DC%2BD28XlsFaksbw%3D
42. M Kanehisa S Goto M Furumichi M Tanabe M Hirakawa 2010 KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res. 38 355 360 10.1093/nar/gkp896
43. SR Khetani SN Bhatia 2008 Microscale human liver tissue for drug development Nat. Biotechnol. 26 120 126 18026090 10.1038/nbt1361 1:CAS:528:DC%2BD1cXisFGlsg%3D%3D
44. S Kidambi R Yarmush E Novik PB Chao ML Yarmush Y Nahmias 2009 Oxygen-mediated enhancement of metabolism, functional polarization, gene expression, and drug clearance in co-cultures of primary hepatocytes PNAS 106 15714 15719 19720996 10.1073/pnas.0906820106 1:CAS:528:DC%2BD1MXhtFyjsLnI
45. H Kimura H Nakayama T Yamamoto Y Sakai T Fujii 2009 Development of on chip co culture system for cytotoxicity test using Caco-2 and HepG2 IEEJ 129 252 258
46. H Kimura T Yamamoto H Sakai Y Sakai T Fujii 2008 An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models" Lab Chip 8 741 746 18432344 10.1039/b717091b 1:CAS:528:DC%2BD1cXltVGquro%3D (Pubitemid 351585451)
47. K Korn E Krausz 2007 Cell-based high-content screening of small-molecule libraries Curr. Opin. Chem. Biol. 11 503 510 17931958 10.1016/j.cbpa.2007.08.030 1:CAS:528:DC%2BD2sXhtF2rsbrP (Pubitemid 47589005)
48. E Leclerc Y Sakai T Fujii 2003 Cell culture in 3-dimensional microfluidic structure of PDMS (polydimethylsiloxane) Biomed. Microdev. 5 2 109 114 10.1023/A:1024583026925 1:CAS:528:DC%2BD3sXltVemtrY%3D (Pubitemid 36986742)
49. E Leclerc Y Sakai T Fujii 2004 Perfusion culture of fetal human hepatocytes in microfluidic-environments Biochem. Eng. J. 20 143 148 10.1016/j.bej.2003.09.010 1:CAS:528:DC%2BD2cXltF2qt7o%3D (Pubitemid 38829558)
50. E Leclerc Y Sakai T Fujii 2004 Microfluidic PDMS (polydimethylsiloxane) bioreactors for large scale culture of hepatocytes Biotech. Prog. 20 750 755 10.1021/bp0300568 1:CAS:528:DC%2BD2cXhs1yitLs%3D (Pubitemid 38784012)
51. P Lee T Gaige P Hung 2011 Microfluidic systems for live cell imaging Methods Cell Biol. 102 77 103 21704836 10.1016/B978-0-12-374912-3.00004-3
52. P Lee N Ghorashian T Gaige P Hung 2007 Microfluidic system for automated cell based assays J. Assoc. Lab. Autom. 12 363 367 10.1016/j.jala.2007.07.001 (Pubitemid 350082722)
53. S Lee BJ Howell 2006 High-content screening: emerging hardware and software technologies Methods Enzymol. 414 468 483 17110207 10.1016/S0076- 6879(06)14025-2 1:CAS:528:DC%2BD2sXmtFKiur0%3D (Pubitemid 44716237)
54. MY Lee RA Kumar SM Sukumaran MG Hogg DS Clark JS Dordick 2008 Three-dimensional cellular microarray for high-throughput toxicology assays Proc. Natl Acad. Sci. USA 105 59 63 18160535 10.1073/pnas.0708756105 1:CAS:528:DC%2BD1cXpvV2ktg%3D%3D
55. B Ma G Zhang J Qin B Lin 2009 Characterization of drug metabolites and cytotoxicity assay simultaneously using an integrated microfluidic device Lab Chip 9 232 238 19107278 10.1039/b809117j 1:CAS:528:DC%2BD1cXhsFakur3N
56. G Madalinski E Godat S Alves D Lesage E Genin P Levi J Labarre JC Tabet E Ezan C Junot 2009 Direct introduction of biological samples into a LTQ-Orbitrap hybrid mass spectrometer as a tool for fast metabolome analysis Anal. Chem. 80 3291 3303 10.1021/ac7024915 (Pubitemid 351620715)
57. GJ Mahler MB Esch RP Glahn ML Shuler 2009 Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity Biotechnol. Bioeng. 104 193 205 19418562 10.1002/bit.22366 1:CAS:528:DC%2BD1MXptVGlu7s%3D
58. PM Midwoud GMM van Groothuis Merema MT Merema E Verpoorte 2010 Microfluidic biochip for the perifusion of precision-cut rat liver slices for metabolism and toxicology studies Biotech. Bioeng. 105 184 194 10.1002/bit.22516
59. PM Midwoud MT van Merema E Verpoorte GMM Groothuis 2010 A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices Lab Chip 10 2778 2786 20835427 10.1039/c0lc00043d
60. JK Nicholson J Connelly JC Lindon E Holmes 2002 Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discov. 1 153 161 12120097 10.1038/nrd728 1:CAS:528:DC%2BD38Xhs1aksbw%3D (Pubitemid 41646523)
61. JK Nicholson JC Lindon E Holmes 1999 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1181 1189 10598751 10.1080/004982599238047 1:CAS:528: DyaK1MXns12ms7k%3D
62. E Novik TJ Maguire P Chao KC Cheng ML Yarmush 2010 A microfluidic hepatic coculture platform for cell-based drug metabolism studies Biochem. Pharmacol. 79 1036 1044 19925779 10.1016/j.bcp.2009.11.010 1:CAS:528:DC%2BC3cXhtlais7Y%3D
63. S Paine A Parker P Gardiner P Webborn R Riley 2008 Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes Drug Metab. Dispos. 36 1365 1374 18426955 10.1124/dmd.107.019455 1:CAS:528:DC%2BD1cXotVensr8%3D (Pubitemid 351929321)
64. KS Pang M Rowland 1977 Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation J. Pharmacokinet. Biopharm. 5 655 680 599412 10.1007/BF01059689 1:CAS:528:DyaE1cXhtlSlur4%3D (Pubitemid 8253671)
65. KS Pang M Rowland 1977 Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance J. Pharmacokinet. Biopharm. 5 625 653 599411 10.1007/BF01059688 1:CAS:528:DyaE1cXhtFGjtLs%3D (Pubitemid 8253670)
66. Y Paran M Ilan Y Kashman S Goldstein Y Liron B Geiger, et al. 2007 High-throughput screening of cellular features using high-resolution light-microscopy; application for profiling drug effects on cell adhesion J. Struct. Biol. 158 233 243 17321150 10.1016/j.jsb.2006.12.013 1:CAS:528:DC%2BD2sXlt1alsrw%3D (Pubitemid 46719994)
67. O Pelkonen M Turpeinen 2007 In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations Xenobiotica. 37 1066 1089 17968737 10.1080/00498250701620726 1:CAS:528:DC%2BD2sXht1ahu7vM (Pubitemid 350035539)
68. MJ Powers D Janigan KE Wack CS Baker DB Stolz L Griffith 2002 Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor Tissue Eng. 8 499 508 12167234 10.1089/107632702760184745 (Pubitemid 34747805)
69. JM Prot C Aninat L Griscom F Razan C Brochot C Guguen Guillouzo C Legallais A Corlu E Leclerc 2011 Improvement of HepG2/C3a cell functions in a microfluidic biochip Biotechnol. Bioeng. 108 1704 1715 21337338 10.1002/bit.23104 1:CAS:528:DC%2BC3MXmtFyltr4%3D
70. JM Prot AS Briffaut F Letourneur P Chafey F Merlier Y Grandvalet C Legallais E Leclerc 2011 Integrated proteomic and transcriptomic investigation highlights original insight into paracetamol toxicity in liver biochip PLoS One 6 e21268 21857903 10.1371/journal.pone.0021268 1:CAS:528:DC%2BC3MXhtFanur%2FI
71. Prot, J. M., A. Bunescu, B. Elena-Hermann, C. Aninat, L. Choucha-Snouber, L. Griscom, F. Bois, C. Cécile Legallais, C. Céline Brochot, A. Anne Corlu, M. D. Dumas, and E. Leclerc. Alternative method in predictive toxicology using systemic biology on chip: application to acetaminophen injury. Toxicol. Appl. Pharmacol., 2011 (to appear).
72. JM Prot O Videau C Brochot C Legallais H Benech E Leclerc 2011 A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening Int. J. Pharm. 408 67 75 21295126 10.1016/j.ijpharm.2011.01.054 1:CAS:528: DC%2BC3MXktFahsrw%3D
73. R Riley DF McGinnity RP Austn 2005 A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocyte and microsomes Drug Metab. Dispos. 33 1304 1311 15932954 10.1124/dmd.105.004259 1:CAS:528:DC%2BD2MXpsFamt74%3D (Pubitemid 41196973)
74. S Sheikh-Bahaei SHJ Kim S Sheikh-Bahaei CA Hunt 2009 Understanding the role of liver zonation in toxin elimination Int. J. Intell. Control Syst. 14 33 40
75. Y Shibata H Takahashi M Chiba Y Ishii 2002 Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method Drug Metab. Dispos. 30 892 896 12124306 10.1124/dmd.30.8.892 1:CAS:528:DC%2BD38XlslWiu7s%3D (Pubitemid 34815418)
76. Y Shibata H Takahashi Y Ishii 2000 A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum Drug Metab. Dispos. 28 1518 1523 11095592 1:CAS:528:DC%2BD3cXos1Srs7Y%3D
77. Shintu, L., R. Baudoin, V. Navratil, J. M. Prot, C. Pontoizeau, M. Defernez, B. Blaise, C. Domange, A. Péry, P. Toulhoat, C. Legallais, C. Brochot, E. Leclerc, and M. E. Dumas. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic. Bioartificial organs. Anal. Chem., 2011 (to appear).
78. A Sivaraman JK Leach S Townsend T Iida BJ Hogan DB Stolz R Fry LD Samson SR Tannenbaum LG Griffith 2005 A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction Curr. Drug Metab. 6 569 592 16379670 10.2174/138920005774832632 1:CAS:528: DC%2BD2MXht1GrurvM (Pubitemid 41672495)
79. JH Sung C Kam MJ Shuler 2010 A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip Lab Chip 10 446 455 20126684 10.1039/b917763a 1:CAS:528:DC%2BC3cXhtlGiu7g%3D
80. A Tilles H Baskaran P Roy M Yarmush M Toner 2001 Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor Biotech. Bioeng. 73 379 389 10.1002/bit.1071 1:CAS:528:DC%2BD3MXjslWhuro%3D (Pubitemid 32493234)
81. YC Toh TC Lim D Tai G Xiao D van Noort H Yu 2009 A microfluidic 3D hepatocyte chip for drug toxicity testing Lab Chip 9 2026 2031 19568671 10.1039/b900912d 1:CAS:528:DC%2BD1MXnvVOrt74%3D
82. K Viravaidya ML Shuler 2004 Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies Biotechnol. Prog. 20 590 597 15059006 10.1021/bp034238d 1:CAS:528: DC%2BD3sXps1ymt7s%3D (Pubitemid 38459166)
83. GM Walker HC Zeringue DJ Beebe 2004 Microenvironment design considerations for cellular scale studies Lab Chip 4 91 97 15052346 10.1039/b311214d 1:CAS:528:DC%2BD2cXksFaltLk%3D (Pubitemid 38525298)
84. DK Wood DM Weingeist SN Bhatia BP Engelward 2010 Single cell trapping and DNA damage analysis using microwell arrays PNAS 107 10008 10013 20534572 10.1073/pnas.1004056107 1:CAS:528:DC%2BC3cXnvVSmtbk%3D
85. H Yu I Meyvantsson IA Shkel DJ Beebe 2005 Diffusion dependent cell behavior in microenvironments Lab Chip 5 1089 1095 16175265 10.1039/b504403k 1:CAS:528:DC%2BD2MXhtVWmu7rK (Pubitemid 41452999)
86. S Zhang W Tong B Zheng T Susanto L Xia C Zhang A Ananthanarayanan X Tuo R Sakban R Jia C Iliescu KH Chai M McMillian S Shen H Leo H Yu 2011 Robust high-throughput sandwich cell-based drug screening platform Biomaterials 32 1229 1241 20971505 10.1016/j.biomaterials.2010.09.064 1:CAS:528:DC%2BC3cXhsVOntbrP
87. C Zhang Z Zhao N Abdul Rahim D van Noort H Yu 2009 Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments Lab Chip 9 3165 3312 10.1039/b921043c
88. J Zuegge G Schneider P Coassolo T Lave 2001 Prediction of hepatic metabolic clearance: comparison and assessment of prediction models Clin. Pharmacokinet. 40 553 563 11510631 10.2165/00003088-200140070-00006 1:CAS:528:DC%2BD3MXms1ars7o%3D (Pubitemid 32738661)